This bill increases federal deposit insurance coverage for noninterest-bearing transaction accounts (like standard checking accounts used for daily payments) up to $10 million per depositor at each bank or credit union. It directly affects individuals and small businesses holding these accounts, expanding protection beyond the standard $250,000 limit for most deposits. The coverage excludes accounts at very large banks (global systemically important bank holding companies) and foreign bank branches, and requires a 10-year phase-in period for full implementation. The bill defines qualifying accounts as those without interest, allowing easy electronic payments without advance withdrawal notices.
HR 7391, the Community Health Center Drug Pricing Protection Act, requires that Federally Qualified Health Centers (FQHCs) pay the discounted 340B ceiling price for covered drugs **at the time of purchase**, not later through rebates or adjustments. This directly affects FQHCs, which rely on 340B discounts to provide affordable care to low-income patients. The bill amends the Public Health Service Act to prohibit manufacturers from entering agreements where FQHCs initially pay more than the ceiling price, with later reimbursement. It takes effect immediately upon enactment for all new drug purchases and applies to existing agreements starting then.
This bill prohibits federal officials from using settlement agreements to direct payments to third parties unless those payments directly compensate for actual harm caused by the defendant or pay for services rendered in the case. It prevents the government from creating slush funds through settlements that benefit unrelated organizations or individuals beyond the scope of direct restitution. Federal agencies must annually report to the Congressional Budget Office on settlement payments that meet the new criteria, while agency inspectors general must audit and publicly report any violations. The reporting and audit requirements are set to expire seven years after the law takes effect.
This bill requires the National Highway Traffic Safety Administration to establish new safety standards for side underride guards on trucks and trailers within 18 months, with full compliance required within two years. The standards mandate that these guards prevent passenger vehicles from sliding under trucks during collisions, improve safety for vulnerable road users like motorcyclists, and include aerodynamic features to aid fuel efficiency. The bill also creates an advisory committee to monitor underride safety and mandates studies to better understand and prevent these crashes. It aims to reduce the thousands of deaths and injuries from underride crashes that have occurred over the past 50 years, as documented by the National Transportation Safety Board.
HR 7363, the ICE Out of Our Faces Act, prohibits U.S. Customs and Border Protection (CBP) and U.S. Immigration and Customs Enforcement (ICE) officers from using facial recognition, voice recognition, or other biometric surveillance technology for immigration enforcement. It directly affects CBP and ICE officers, including those deputized under Section 287(g), by banning the acquisition, possession, or use of such technology within the U.S. The bill requires immediate deletion of all existing biometric data collected by these agencies within 30 days of enactment and makes illegally obtained data inadmissible in court. Individuals harmed by violations can sue the federal government for damages, while officers violating the law face retraining, suspension, or termination.
SJRES 102 is a congressional resolution disapproving the District of Columbia Council's approval of the D.C. Income and Franchise Tax Conformity and Revision Temporary Amendment Act of 2025 (D.C. Act A26-0217). This resolution, introduced by Senator Scott on January 27, 2026, aims to block the D.C. tax law from taking effect by invoking Congress's disapproval authority under the District of Columbia Home Rule Act. The bill directly affects D.C. residents and businesses subject to the income and franchise tax provisions in the disapproved law. If passed, it would prevent the D.C. tax code changes from becoming effective.
HRES 1039 is a symbolic resolution supporting National Black HIV/AIDS Awareness Day observed annually on February 7. It highlights that Black Americans account for disproportionate HIV impacts (e.g., 39% of new diagnoses despite representing 12% of the U.S. population) and urges state/local health agencies to promote HIV testing, reduce stigma, and prioritize minority-led HIV services. The resolution encourages alignment with the National HIV/AIDS Strategy and emphasizes culturally competent care, but does not create new funding or enforceable requirements. It serves as a non-binding endorsement of existing efforts to address racial disparities in HIV prevention and treatment.
HRES 1002 is a symbolic House resolution recognizing the Older Americans Act (OAA) nutrition program, which provides meals and social services to seniors aged 60+. It directly affects millions of older adults - particularly those who are homebound, isolated, or facing hunger, malnutrition, or chronic health conditions - by highlighting how the program reduces hospital visits, lowers healthcare costs, and improves quality of life. Key provisions include acknowledging the program’s role in preventing falls and institutionalization, emphasizing volunteer support as its "backbone," and urging Congress to secure sustained federal funding. As a non-binding resolution, it does not change policy but formally endorses the program’s value and calls for community and legislative support.
HR 7385 establishes a federal grant program to expand access to HIV prevention through PrEP (pre-exposure prophylaxis) for uninsured individuals at high risk of HIV infection. The bill authorizes $400 million annually (2027-2031) to fund grants for eligible entities like clinics, community organizations, and tribal governments to cover PrEP-related costs - including medication, testing, counseling, and transportation - without requiring patient payment. Priority is given to programs serving rural areas, uninsured populations, or high-risk demographic groups, with grantees required to contribute 10% of program costs (except for certain health centers). The program also mandates a "PrEP Pass" card system to streamline access and requires annual reports tracking usage by race, gender, age, and location to measure impact on HIV prevention disparities.
This bill creates new funding eligibility for Historically Black Colleges and Universities (HBCUs) and Predominantly Black Institutions (PBIs) that offer approved master's degree programs. It amends existing law to add specific categories (subsections S for HBCUs and F for PBIs) allowing these institutions to access federal funds previously restricted to certain program types. The key mechanism expands funding access by adjusting how remaining funds are allocated after initial disbursements. Directly affects qualifying HBCUs and PBIs meeting both the institution type and master's program criteria.
This bill prohibits petroleum refineries from using hydrofluoric acid (HF) for gasoline production. New refineries cannot use HF after the law takes effect, and existing refineries must switch to safer alternatives within 5 years. Refineries that fail to comply face a $37,500 civil penalty per violation, and the law blocks waivers for this requirement. The measure targets 40 refineries using HF - potentially exposing 14 million nearby residents to severe health risks - and mandates adoption of commercially available, safer refining methods already used in most U.S. refineries.
The PASTEUR Act of 2026 creates a new government contracting program to incentivize development of new antimicrobial drugs for treating drug-resistant infections. The Health and Human Services Secretary would award contracts to pharmaceutical sponsors meeting specific criteria on clinical benefits, innovation, and public health impact, with annual payments ranging from $75 million to $300 million (adjusted for inflation). Contract requirements include ensuring drug availability, tracking resistance data, promoting appropriate use, and maintaining supply chains. The bill also establishes antimicrobial stewardship programs for hospitals and outpatient facilities and improves surveillance of antimicrobial use and resistance. This legislation aims to address antibiotic resistance by creating financial incentives for new treatments and improving how antimicrobials are used and monitored.
